Document(s) published by this organization: 484
Show: results per page
|Cybersecurity's Moment and What it Means for Financial Services|
Lisa M. Ledbetter, Todd S. McClelland, Mauricio F. Paez, Albert J. Rota, C. Hunter Wiggins; Jones Day;
April 12, 2016, previously published on March 2016The recent announcement of President Barack Obama's Cybersecurity National Action Plan, with programs aimed at improving the security of public and private data, is a reminder that cybersecurity—including identifying, defending against, recovering from, and notifying others about cyber...
|Brazilian Government Approves Increase in Capital Gains Rates|
S. Wade Angus, Marcello Hallake, Sanjiv K. Kapur, Luis Riesgo; Jones Day;
April 12, 2016, previously published on March 2016In September 2015, the Brazilian federal government proposed a new rule increasing the income tax rates applicable to capital gains payable by certain taxpayers from a transfer or sale of assets or rights, as reported in our Alerts of October 2015 and December 2015. The rule has been approved by...
|Federal Circuit Upholds Broad Hatch-Waxman Venue Options for Innovator Pharmaceutical Companies|
Gregory A. Castanias, Pablo D. Hendler, Matthew J. Hertko, Anthony M. Insogna, Gasper J. LaRosa; Jones Day;
April 12, 2016, previously published on March 2016On March 18, 2016, the United States Court of Appeals for the Federal Circuit issued a combined opinion in Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc., No. 2015-1456, and AstraZeneca AB v. Mylan Pharmaceuticals Inc., No. 2015-1460, holding that an Abbreviated New Drug Application...
|Miami International Commercial Arbitration Court: Another Reason Why Miami Is Becoming the Preferred Seat for Latin American Arbitrations|
Carlos F. Concepcion, Thomas E. Lynch, Ana Maria Cristina Perez Soto, Ricardo Hugo Puente, Johanna Oliver Rousseaux; Jones Day;
April 12, 2016, previously published on March 2016Miami rapidly is becoming the preferred venue for international commercial arbitrations involving Latin American parties. This is so not only because of Miami's geographical proximity to Latin America, large pool of legal professionals with Spanish and Portuguese language capabilities, and close...
|Madden 2016: U.S. Supreme Court Calls for the Views of the Solicitor General in Case with Significant Implications for the Consumer Debt Market|
Traci L. Lovitt, Matthew A. Martel, Anthony M. (Tony) Masero, Joseph B. Sconyers; Jones Day;
April 12, 2016, previously published on March 2016On March 21, 2016, the U.S. Supreme Court announced that it has called for the views of the Solicitor General in connection with the certiorari petition in Madden v. Midland Funding, LLC, 786 F.3d 246 (2d Cir. 2015), a decision restricting non-bank loan purchasers from benefitting from the National...
|BIS Backtrack: U.S. Temporarily Reauthorizes Certain Exports and Reexports to Two ZTE-Affiliated Entities|
Chad O. Dorr, Laura L. Fraedrich, Michael P. Gurdak, Chase David Kaniecki, D. Grayson Yeargin; Jones Day;
April 12, 2016, previously published on March 2016This week, the U.S. Department of Commerce, Bureau of Industry and Security ("BIS") issued a temporary general license that restores certain export, reexport, and transfer privileges to Zhongxing Telecommunications Equipment Corporation ("ZTE Corp.") and ZTE Kangxun...
|Belgium Introduces New Leniency Guidelines on Competition Law Prosecutions|
Bernard E. Amory, Serge Clerckx, Laurent De Muyter, Yvan N. Desmedt, Alexandre G. Verheyden; Jones Day;
April 12, 2016, previously published on March 2016The Belgian Competition Authority ("BCA") has released new guidelines on its leniency program for cartel agreements ("Guidelines"), which entered into force on March 22, 2016. The leniency program, which exists in some form in most other European jurisdictions and the U.S. as...
|Amarin and FDA Agree to Landmark Settlement on Off-Label Promotion|
Michael A. Carvin, Toni-Ann Citera, Colleen Heisey, Karen P. Hewitt, Laura F. Laemmle-Weidenfeld; Jones Day;
April 6, 2016, previously published on March 2016On March 8, 2016, Amarin Pharma, Inc. reached a noteworthy settlement in its lawsuit against the U.S. Food and Drug Administration ("FDA") to protect its First Amendment right to promote the drug Vascepa for nonapproved, off-label uses. Amarin Pharma, Inc. v. FDA (S.D.N.Y. No. 15-cv-3588)...
|Loans Granted by Securitization Vehicles: The Bank of Italy's New Implementing Measures|
Francesco Squerzoni, Vinicio Trombetti; Jones Day;
April 6, 2016, previously published on March 2016On March 8, 2016, after a public consultation process, the Bank of Italy published the implementing measures relating to the supervisory regulations for loans granted by securitization vehicles incorporated under the Italian securitization law (Law No. 130 of April 30, 1999).
|Individuals in the Cross Hairs? What This Means for Directors|
John T. Sullivan, David Ronald Woodcock; Jones Day;
April 5, 2016, previously published on March 2016Following the 2008 financial crisis, government regulators and prosecutors have been under tremendous public pressure to prosecute individuals.Senior government officials have responded by speaking forcefully about their desires to sue or prosecute more individuals. What does the government's...